Clinical Trial: To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Safety and Tolerability Study of Sublingual Lobeline

Brief Summary: To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.

Detailed Summary: The primary objective of this study is to characterize the pharmacokinetics of three ascending doses of lobeline in normal volunteers.
Sponsor: National Institute on Drug Abuse (NIDA)

Current Primary Outcome: Safety

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: National Institute on Drug Abuse (NIDA)

Dates:
Date Received: December 22, 2004
Date Started: September 2004
Date Completion: April 2005
Last Updated: January 10, 2017
Last Verified: December 2004